TEVA PHARMACEUTICALS USA, INC.
- Unique Entity ID (UEI)
- NEN9A34LRHJ5
- Parent company
- TEVA PHARMACEUTICALS USA, INC. (this vendor is its own parent)
- Registered address
- PARSIPPANY, NJ, district NJ-11
- Other names on record
- TEVA PHARMACEUTICALS USA INC.; TEVA PHARMACEUTICALS USA INC; TEVA PHARMACEUTICALS USA INCORPORATED
Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.
Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 19, 2026.
Which agencies pay this vendor, and where the work is done
Fiscal year 2027
USAspending lists no contract dollars for this vendor in fiscal year 2027 yet.
Fiscal year 2026: $34,980,236.55
| Agency | Contract dollars |
|---|---|
| Department of Defense | $34,980,236.55 |
| District where the work is done | Contract dollars |
|---|---|
| NJ-11Analilia Mejia | $34,980,236.55 |
Largest awards
The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.
| Award | Agency | Where the work is done | Award total | Start |
|---|---|---|---|---|
| SPE2DP26F35868511984334!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $3,950,553.60 | Ends March 25, 2026 |
| SPE2DP26F28148511918533!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $3,950,553.60 | Ends February 24, 2026 |
| SPE2DP26F16498511856699!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $3,950,553.60 | Ends January 27, 2026 |
| SPE2DP26F09798511784063!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $1,981,883.16 | Ends December 9, 2025 |
| SPE2DP26F09808511784064!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $1,321,255.44 | Ends December 9, 2025 |
| SPE2DP26F65138512183379!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $1,202,342.40 | Ends June 23, 2026 |
| SPE2DP26F74508512238186!ADENOVIRUS TYPE 4 AND TYPE 7 | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $1,030,579.20 | Ends July 21, 2026 |
| SPE2DP26F65148512183483!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $1,030,579.20 | Ends June 23, 2026 |
| SPE2DP26F54668512097239!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $1,030,579.20 | Ends May 19, 2026 |
| SPE2DP26F46338512041924!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $1,030,579.20 | Ends April 29, 2026 |
| SPE2DP26F74868512238379!ADENOVIRUS TYPE 4 AND TYPE 7 | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $687,052.80 | Ends July 21, 2026 |
| SPE2DP26F65188512183579!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $687,052.80 | Ends June 23, 2026 |
| SPE2DP26F54698512097278!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $687,052.80 | Ends May 19, 2026 |
| SPE2DP26F46368512042006!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $687,052.80 | Ends April 29, 2026 |
| SPE2DP26F09838511784112!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $660,627.72 | Ends December 9, 2025 |
| SPE2DP26F09828511784111!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $660,627.72 | Ends December 9, 2025 |
| SPE2DP26F74908512238423!ADENOVIRUS TYPE 4 AND TYPE 7 | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $515,289.60 | Ends July 21, 2026 |
| SPE2DP26F74498512238185!ADENOVIRUS TYPE 4 AND TYPE 7 | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $515,289.60 | Ends July 21, 2026 |
| SPE2DP26F65308512184053!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $515,289.60 | Ends June 23, 2026 |
| SPE2DP26F65158512183485!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $515,289.60 | Ends June 23, 2026 |
| SPE2DP26F54738512097419!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $515,289.60 | Ends May 19, 2026 |
| SPE2DP26F54718512097411!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $515,289.60 | Ends May 19, 2026 |
| SPE2DP26F46398512042110!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $515,289.60 | Ends April 29, 2026 |
| SPE2DP26F46378512042008!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $515,289.60 | Ends April 29, 2026 |
| SPE2DP26F75068512238428!ADENOVIRUS TYPE 4 AND TYPE 7 | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends July 21, 2026 |
| SPE2DP26F74718512238378!ADENOVIRUS TYPE 4 AND TYPE 7 | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends July 21, 2026 |
| SPE2DP26F74568512238187!ADENOVIRUS TYPE 4 AND TYPE 7 | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends July 21, 2026 |
| SPE2DP26F65318512184059!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends June 23, 2026 |
| SPE2DP26F65178512183572!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends June 23, 2026 |
| SPE2DP26F65168512183571!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends June 23, 2026 |
| SPE2DP26F54728512097415!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends May 19, 2026 |
| SPE2DP26F54688512097273!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends May 19, 2026 |
| SPE2DP26F54678512097271!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends May 19, 2026 |
| SPE2DP26F46388512042009!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends April 29, 2026 |
| SPE2DP26F46358512042003!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends April 29, 2026 |
| SPE2DP26F46348512042000!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends April 29, 2026 |
| SPE2DP26F35878511984336!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $343,526.40 | Ends March 25, 2026 |
| SPE2DP26F09858511784115!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $330,313.86 | Ends December 9, 2025 |
| SPE2DP26F09848511784113!ADENOVIRUS TYPE 4 A | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $330,313.86 | Ends December 9, 2025 |
| SPE2DP26F75128512238522!ADENOVIRUS TYPE 4 AND TYPE 7 | Department of DefenseDefense Logistics Agency | PARSIPPANY, NJ-11 | $171,763.20 | Ends July 21, 2026 |
Subcontracts it reported
A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.
No subcontract is reported under this vendor’s largest awards.
Lobbying reports and campaign receipts that name this vendor
A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.
Lobbying reports that name TEVA PHARMACEUTICALS USA, INC.
How it matched: vendor name, exact name: the name in the lobbying report as client.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| FAEGRE DRINKER BIDDLE & REATH LLP | TEVA PHARMACEUTICALS USA, INC. | $60,000reported as income | Third quarter of 2026 | Open the report | |
| TEVA PHARMACEUTICALS USA, INC. | TEVA PHARMACEUTICALS USA INC | $310,000reported as expenses | Third quarter of 2026 | Open the report |